GONZALO BECERRA: Open Payments
NPI 1750518106 · GREENVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,448 in 147 payments from 31 companies in 2025. Trend: 2023 $2,276 · 2024 $1,519 · 2025 $2,448
Food & beverage: $2,416Education: $32
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 29 | $284 |
| ABBVIE INC. | 19 | $252 |
| PFIZER INC. | 13 | $189 |
| Novo Nordisk Inc | 10 | $189 |
| AstraZeneca Pharmaceuticals LP | 7 | $185 |
| GlaxoSmithKline, LLC. | 14 | $176 |
| Xeris Pharmaceuticals, Inc. | 3 | $145 |
| Novartis Pharmaceuticals Corporation | 7 | $127 |
| TOLMAR, INC. | 5 | $113 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $89 |
Products named: OTEZLA, VRAYLAR, GVOKE HYPOPEN, LEQVIO, TRELEGY ELLIPTA, JATENZO, BREZTRI, ELIQUIS.
Industry payments across NC — which companies pay providers there.
